128 related articles for article (PubMed ID: 12602979)
1. Long-term remission of recalcitrant tumour-stage mycosis fungoides following chemotherapy with pegylated liposomal doxorubicin.
Tsatalas C; Martinis G; Margaritis D; Spanoudakis E; Kotsianidis I; Karpouzis A; Bourikas G
J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):80-2. PubMed ID: 12602979
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin.
Wollina U; Graefe T; Karte K
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):40-6. PubMed ID: 10607318
[TBL] [Abstract][Full Text] [Related]
3. Pegylated liposomal doxorubicin in stage IVB mycosis fungoides.
Di Lorenzo G; Di Trolio R; Delfino M; De Placido S
Br J Dermatol; 2005 Jul; 153(1):183-5. PubMed ID: 16029347
[TBL] [Abstract][Full Text] [Related]
4. Pegylated liposomal doxorubicin in the treatment of mycosis fungoides.
Lybaek D; Iversen L
Acta Derm Venereol; 2006; 86(6):545-7. PubMed ID: 17106606
[No Abstract] [Full Text] [Related]
5. Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012.
Dummer R; Quaglino P; Becker JC; Hasan B; Karrasch M; Whittaker S; Morris S; Weichenthal M; Stadler R; Bagot M; Cozzio A; Bernengo MG; Knobler R
J Clin Oncol; 2012 Nov; 30(33):4091-7. PubMed ID: 23045580
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy in the tumour stage of mycosis fungoides with cyclophosphamide, vincristine, vp-16, adriamycin and prednisolone (cop, chop, cavop): a report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G; Groth O; Hellbe L; Holst R; Knudsen EA; Roupe G; Schmidt H
Acta Derm Venereol; 1980; 60(6):542-4. PubMed ID: 6162347
[TBL] [Abstract][Full Text] [Related]
7. Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome.
Janiga J; Kentley J; Nabhan C; Abdulla F
Leuk Lymphoma; 2018 Mar; 59(3):562-577. PubMed ID: 29308723
[TBL] [Abstract][Full Text] [Related]
8. Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.
Pulini S; Rupoli S; Goteri G; Pimpinelli N; Alterini R; Tassetti A; Scortechini AR; Offidani M; Mulattieri S; Stronati A; Brandozzi G; Giacchetti A; Mozzicafreddo G; Ricotti G; Filosa G; Bettacchi A; Simonacci M; Novelli N; Leoni P
Haematologica; 2007 May; 92(5):686-9. PubMed ID: 17488695
[TBL] [Abstract][Full Text] [Related]
9. Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series.
Lewis DJ; Byekova YA; Emge DA; Duvic M
J Dermatolog Treat; 2017 Sep; 28(6):567-569. PubMed ID: 28635518
[TBL] [Abstract][Full Text] [Related]
10. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
[TBL] [Abstract][Full Text] [Related]
11. Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma.
Prince HM; Seymour JF; Ryan G; McCormack C
J Am Acad Dermatol; 2001 Jan; 44(1):149-50. PubMed ID: 11148501
[No Abstract] [Full Text] [Related]
12. A case of advanced mycosis fungoides with comprehensive skin and visceral organs metastasis: sensitive to chemical and biological therapy.
Liu YQ; Zhu WY; Shu YQ; Gu YH
Asian Pac J Trop Med; 2012 Aug; 5(8):669-72. PubMed ID: 22840460
[TBL] [Abstract][Full Text] [Related]
13. Solitary plaque mycosis fungoides on the penis responding to topical imiquimod therapy.
Chiam LY; Chan YC
Br J Dermatol; 2007 Mar; 156(3):560-2. PubMed ID: 17300249
[TBL] [Abstract][Full Text] [Related]
14. Unilesional mycosis fungoides successfully treated with imiquimod.
Ardigò M; Cota C; Berardesca E
Eur J Dermatol; 2006; 16(4):446. PubMed ID: 16935811
[No Abstract] [Full Text] [Related]
15. Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome.
Quereux G; Marques S; Nguyen JM; Bedane C; D'incan M; Dereure O; Puzenat E; Claudy A; Martin L; Joly P; Delaunay M; Beylot-Barry M; Vabres P; Celerier P; Sasolas B; Grange F; Khammari A; Dreno B
Arch Dermatol; 2008 Jun; 144(6):727-33. PubMed ID: 18559761
[TBL] [Abstract][Full Text] [Related]
16. Adriamycin therapy in advanced mycosis fungoides.
Levi JA; Diggs CH; Wiernik PH
Cancer; 1977 May; 39(5):1967-70. PubMed ID: 858126
[TBL] [Abstract][Full Text] [Related]
17. Interferon-based treatment for patients with mycosis fungoides and hepatitis C virus infection: a case series.
Kyvernitakis A; Duvic M; Mahale P; Torres HA
Am J Clin Dermatol; 2014 Oct; 15(5):451-6. PubMed ID: 24934807
[TBL] [Abstract][Full Text] [Related]
18. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine.
Heisig M; Maj J; Szepietowski JC; Reich A
Dermatol Ther; 2016; 29(1):15-8. PubMed ID: 26278921
[TBL] [Abstract][Full Text] [Related]
19. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
20. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread.
Roupe G; Sandström MH; Kjellström C
Acta Derm Venereol; 1996 Nov; 76(6):475-8. PubMed ID: 8982416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
